The Medicines Law & Policy team has published widely on a variety of issues related to access to and innovation on essential medicines, including: international intellectual property policy and its impact on access to medicines, in particular on policies coming out of the World Trade Organization, the World Health Organization, and the World Intellectual Property Organization; options for innovative ways to create incentives for research and development, in particular on medical products for diseases disproportionately affecting developing countries; and on the lessons the access to HIV movement has for the access to medicines crises of the future. Below is a selection of relevant publications by ML&P staff.

Watch Ellen ‘t Hoen’s TED Talk “Pool medical patents, save lives.”

All Publications


An ML&P series of briefing documents that aims to contribute to the discussion on high medicines prices in Europe, in particular those that result from market exclusivity.
A UNITAID discussion paper on options for ensuring medicines on the WHO's Model List of Essential Medicines are available and affordable.
An evaluation of use of TRIPS flexibilities and how they can be practically implemented for better health outcomes.
Ellen 't Hoen's 2016 book traces the rise of strict patent regimes, and analysis options to ensure medicines access.
The Lancet Commission Report on Essential Medicines Policies: an expert report on how to ensure universal access to affordable care.
Data exclusivity laws may impede the effective use of CLs; this paper outlines exceptions to facilitate access to medicines.